Aspirin and Preeclampsia
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 180 participants.
Also called NCT04479072
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 180 participants
- Sponsor
- Registry
-
NCT04479072
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT04479072. Randomized; double masking; primary purpose prevention. Start 2021-02-15 (actual); primary completion 2026-12-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Aspirin and Preeclampsia
- Condition
- Preeclampsia Postpartum
- Intervention (Drug)
- Aspirin 81 mg
- Intervention (Drug)
- Placebo
- Lead sponsor
- University of Chicago
Record details
- Record id
cardio:ct-nct04479072- Content hash
b41435aa56ea6dd99a5cea02a18e2bff36783f7628322c933a7efdc33793afb4